A 4-Way Placebo And Active Controlled Study To Evaluate The Effects Of Fesoterodine On Cognitive Function In Healthy Elderly Subjects.

Trial Profile

A 4-Way Placebo And Active Controlled Study To Evaluate The Effects Of Fesoterodine On Cognitive Function In Healthy Elderly Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 20 Feb 2013

At a glance

  • Drugs Fesoterodine (Primary) ; Alprazolam
  • Indications Generalised anxiety disorder; Overactive bladder; Panic disorder
  • Focus Adverse reactions
  • Most Recent Events

    • 02 Sep 2011 Results presented at the 41st Annual Meeting of the International Continence Society.
    • 14 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 09 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top